COMP <GO>
AFRI vs MED // 10Y YIELD & FRED MACRO BETA
Forafric Global PLC (NASDAQ) VS. MEDIFAST INC (NYSE) • 15-METRIC TALLY: AFRI 4
— MED 7
■ METRIC PARITY
LAST: $12.63 (-0.08%) • MKT CAP: $340.6M
macro-sensitivity
—
LAST: $12.26 (-0.16%) • MKT CAP: $137.1M
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AFRI VS. MED)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AFRI | MED | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 10.40% | 71.30% | -60.90 | MED | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -16.50% | -10.20% | -6.30 | MED | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.05% | 0.91% | -0.96 | MED | /fcf-yield <GO> |
| Operating Margin | -2.00% | -3.70% | +1.70 | AFRI | /operating-margins <GO> |
| Net Profit Margin | -8.40% | -4.90% | -3.50 | MED | /net-margins <GO> |
| Revenue Growth (YoY) | -35.60% | -36.00% | +0.40 | AFRI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.14% | -0.14 | MED | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 4.71 | -4.51 | MED | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 5/9 | -2.00 | MED | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 62.0 | 54.3 | +7.76 | AFRI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $340.6M | $137.1M | $203.5M | AFRI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AFRI REV | MED REV | AFRI GROSS % | MED GROSS % | AFRI FCF | MED FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $176.5M | $385.8M | 10.4% | 71.3% | -$161.0K | $1.2M |
| FY 2024 | $274.2M | $602.5M | 10.0% | 73.8% | $21.7M | $17.0M |
| FY 2023 | $302.0M | $1.07B | — | — | $33.3M | $147.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AFRI // BETA —
MED // BETA —